Evidence map›Paper›PMID 31052540›Full record

ArticlePolymers2019

Butylglyceryl Pectin Nanoparticles: Synthesis, Formulation and Characterization.

Mohammad F Bostanudin, Mosab Arafat, Muhammad Sarfraz, Dariusz C Górecki, Eugen Barbu

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 29 citations in OpenAlex.

  1. Pectin hydrogels for controlled drug release: Recent developments and future prospects.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Development and In Vitro Evaluation of Controlled Release ViagraPharmaceuticals (Basel, Switzerland) · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mohammad F BostanudinCollege of Pharmacy, Al Ain University of Science and Technology, Abu Dhabi 112612, UAE. mohammad.bostanudin@aau.ac.ae.ORCID 0000-0002-7311-9956
Mosab ArafatCollege of Pharmacy, Al Ain University of Science and Technology, Al Ain 64141, UAE. mosab.arafat@aau.ac.ae.ORCID 0000-0001-9297-6745
Muhammad SarfrazCollege of Pharmacy, Al Ain University of Science and Technology, Al Ain 64141, UAE. muhammad.sarfraz@aau.ac.ae.
Dariusz C GóreckiSchool of Pharmacy and Biomedical Sciences, University of Portsmouth, St Michael's Building, Portsmouth PO1 2DT, UK. darek.gorecki@port.ac.uk.
Eugen BarbuSchool of Pharmacy and Biomedical Sciences, University of Portsmouth, St Michael's Building, Portsmouth PO1 2DT, UK. eugen.barbu@port.ac.uk.ORCID 0000-0002-2053-4136
Al Ain University · AEUniversity of Portsmouth · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pectin is a polysaccharide with very good gel forming properties that traditionally has found important applications in foods and pharmaceutical industries. Although less studied, chemical modifications of pectin leading to a decrease in its hydrophilicity can be useful for the development of novel drug carriers. To this aim, butylglyceryl pectins (P-OX4) were synthesized via functionalization with

Indexed as

alkylglycerolsnanoparticlesN-butylglycidyl etherpectinpolysaccharides

Identifiers

PMID31052540
PMCPMC6571649
OpenAlexW2942667271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.